These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy. Langness J; Cook PF; Gill J; Boggs R; Netsanet N J Manag Care Spec Pharm; 2014 Aug; 20(8):809-14. PubMed ID: 25062074 [TBL] [Abstract][Full Text] [Related]
4. Once-a-day therapy for HIV infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patients. Maggiolo F; Ripamonti D; Gregis G; Quinzan G; Callegaro A; Arici C; Ravasio L; Suter F Antivir Ther; 2003 Aug; 8(4):339-46. PubMed ID: 14518703 [TBL] [Abstract][Full Text] [Related]
5. The impact of once-nightly versus twice-daily dosing and baseline beliefs about HAART on adherence to efavirenz-based HAART over 48 weeks: the NOCTE study. Cooper V; Horne R; Gellaitry G; Vrijens B; Lange AC; Fisher M; White D J Acquir Immune Defic Syndr; 2010 Mar; 53(3):369-77. PubMed ID: 20087195 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of once-daily regimens in the treatment of HIV infection. Molina JM Drugs; 2008; 68(5):567-78. PubMed ID: 18370438 [TBL] [Abstract][Full Text] [Related]
8. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. Stone VE; Jordan J; Tolson J; Miller R; Pilon T J Acquir Immune Defic Syndr; 2004 Jul; 36(3):808-16. PubMed ID: 15213564 [TBL] [Abstract][Full Text] [Related]
9. Assessing adherence to antiretroviral therapy in randomized HIV clinical trials: a review of currently used methods. Marcellin F; Spire B; Carrieri MP; Roux P Expert Rev Anti Infect Ther; 2013 Mar; 11(3):239-50. PubMed ID: 23458765 [TBL] [Abstract][Full Text] [Related]
10. Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database. Raffi F; Yazdanpanah Y; Fagnani F; Laurendeau C; Lafuma A; Gourmelen J J Antimicrob Chemother; 2015 Jul; 70(7):2121-8. PubMed ID: 25904729 [TBL] [Abstract][Full Text] [Related]
11. Initiation of antiretroviral therapy: implications of recent findings. Saag MS Top HIV Med; 2004; 12(3):83-8. PubMed ID: 15310939 [TBL] [Abstract][Full Text] [Related]
12. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Kanters S; Park JJ; Chan K; Socias ME; Ford N; Forrest JI; Thorlund K; Nachega JB; Mills EJ Lancet HIV; 2017 Jan; 4(1):e31-e40. PubMed ID: 27863996 [TBL] [Abstract][Full Text] [Related]
13. Comment on: Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database. Grammatico-Guillon L; Gras G; Hassen-Khodja C; Maakaroun Z; Bastides F; Barin F; Bernard L J Antimicrob Chemother; 2015 Nov; 70(11):3172-3. PubMed ID: 26253090 [No Abstract] [Full Text] [Related]
14. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs. Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670 [TBL] [Abstract][Full Text] [Related]
15. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents. Jiménez-Montero B; Beceiro J; de José-Gómez MI; González-Tomé MI; Gurbindo-Gutierrez D; Martínez-Pérez J; Mellado-Peña MJ; Navarro-Gómez ML; Roa-Francia MA; Rojo-Conejo P; Saavedra-Lozano J; Jiménez de Ory S; Ramos-Amador JT; Pediatr Infect Dis J; 2014 Oct; 33(10):1052-4. PubMed ID: 24747153 [TBL] [Abstract][Full Text] [Related]
16. Simplifying antiretroviral therapy. Tapper ML; Flexner C; Eron JJ; Molina JM AIDS Read; 2004 Jul; 14(7):355-60, 367-71. PubMed ID: 15282865 [TBL] [Abstract][Full Text] [Related]
17. Once-daily dosing of nevirapine in HAART. Clotet B J Antimicrob Chemother; 2008 Jan; 61(1):13-6. PubMed ID: 18006524 [TBL] [Abstract][Full Text] [Related]
18. Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy. Willig JH; Abroms S; Westfall AO; Routman J; Adusumilli S; Varshney M; Allison J; Chatham A; Raper JL; Kaslow RA; Saag MS; Mugavero MJ AIDS; 2008 Oct; 22(15):1951-60. PubMed ID: 18784459 [TBL] [Abstract][Full Text] [Related]
19. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). Lowe SH; Wensing AM; Hassink EA; ten Kate RW; Richter C; Schreij G; Koopmans PP; Juttmann JR; van der Tweel I; Lange JM; Borleffs JC HIV Clin Trials; 2005; 6(5):235-45. PubMed ID: 16306030 [TBL] [Abstract][Full Text] [Related]
20. Improving adherence to antiretroviral therapy. Daar ES; Cohen C; Remien R; Sherer R; Smith K AIDS Read; 2003 Feb; 13(2):81-2, 85-6, 88-90. PubMed ID: 12645492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]